AAAAAA

   
Results: 1-7 |
Results: 7

Authors: YASUI N KONDO T OTANI K FURUKORI H KANEKO S OHKUBO T NAGASAKI T SUGAWARA K
Citation: N. Yasui et al., EFFECT OF ITRACONAZOLE ON THE SINGLE ORAL DOSE PHARMACOKINETICS AND PHARMACODYNAMICS OF ALPRAZOLAM, Psychopharmacology, 139(3), 1998, pp. 269-273

Authors: SUZUKI A OTANI K MIHARA K YASUI N KONDO T TOKINAGA N FURUKORI H KANEKO S INOUE Y HAYASHI K
Citation: A. Suzuki et al., EFFECTS OF VARIOUS FACTORS INCLUDING THE CYP2D6 GENOTYPE AND COADMINISTRATION OF FLUNITRAZEPAM ON THE STEADY-STATE PLASMA-CONCENTRATIONS OFBROMPERIDOL AND ITS REDUCED METABOLITE, Psychopharmacology, 135(4), 1998, pp. 333-337

Authors: FURUKORI H OTANI K YASUI N KONDO T KANEKO S SHIMOYAMA R OHKUBO T NAGASAKI T SUGAWARA K
Citation: H. Furukori et al., EFFECT OF CARBAMAZEPINE ON THE SINGLE ORAL DOSE PHARMACOKINETICS OF ALPRAZOLAM, Neuropsychopharmacology, 18(5), 1998, pp. 364-369

Authors: YASUI N OTANI K KONDO T SUZUKI A FURUKORI H KANEKO S INOUE Y
Citation: N. Yasui et al., CORRELATION BETWEEN STEADY-STATE PLASMA-CONCENTRATIONS (CSS) OF BROMPERIDOL AND HALOPERIDOL, Progress in neuro-psychopharmacology & biological psychiatry, 22(3), 1998, pp. 485-492

Authors: OTANI K KONDO T YASUI N SUZUKI A FURUKORI H KANEKO S OHKUBO T NAGASAKI T SUGAWARA K HAYASHI K
Citation: K. Otani et al., PROLACTIN RESPONSE TO NEMONAPRIDE, A NEW ANTIPSYCHOTIC DRUG, IN SCHIZOPHRENIC-PATIENTS, Human psychopharmacology, 12(6), 1997, pp. 591-594

Authors: OTANI K YASUI N FURUKORI H KANEKO S TASAKI H OHKUBO T NAGASAKI T SUGAWARA K HAYASHI K
Citation: K. Otani et al., RELATIONSHIP BETWEEN SINGLE ORAL DOSE PHARMACOKINETICS OF ALPRAZOLAM AND TRIAZOLAM, International clinical psychopharmacology, 12(3), 1997, pp. 153-157

Authors: OTANI K ISHIDA M YASUI N KONDO T MIHARA K SUZUKI A FURUKORI H KANEKO S INOUE Y
Citation: K. Otani et al., INTERACTION BETWEEN CARBAMAZEPINE AND BROMPERIDOL, European Journal of Clinical Pharmacology, 52(3), 1997, pp. 219-222
Risultati: 1-7 |